Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Problems of nephrooncology. Proceedings from the 1st Scientific and Training Conference Nephrooncology 5-6 October 2018, Gdańsk, Poland.

Bączkowska T, Bissler JJ, Błasińska‑Przerwa K, Borawski J, Chudek J, Ciechanowski K, Czarkowska‑Pączek B, Dębska-Ślizień A, Domański M, Durlik M, Gellert R, Gozdowska J, Goździk M, Imko‑Walczuk B, Janiszewski J, Januszko‑Giergielewicz B, Jeśkiewicz M, Jóźwiak S, Kadylak D, Klinger M, Kosieradzki M, Kotulska K, Kozak Ł, Król E, Krzanowska K, Kurnatowska I, Labij‑Reduta B, Lichodziejewska‑Niemierko M, Lizakowski S, Małyszko J, Matuszewski M, Mazurkiewicz J, Mełeń‑Mucha G, Myślak M, Naumnik B, Nowicki M, Oko A, Pączek L, Perkowska-Ptasińska A, Piątak M, Piecha G, Radzikowska E, Renke M, Rutkowska B, Sawosz M, Skutecki R, Słowińska M, Sosińska‑Mielcarek K, Szafran‑Dobrowolska J, Szołkowska M, Szczepulska‑Wójcik E, Szurowska E, Tarasewicz A, Wągrowska‑Danilewicz M, Wołowiec D, Woźniak J, Zawiasa‑Bryszewska A.

Pol Arch Intern Med. 2019 May 2;129(Spec. Issue 2):1-74. doi: 10.20452/pamw.14821. Epub 2019 May 2. No abstract available.

2.

A step-wise approach for establishing a multidisciplinary team for the management of tuberous sclerosis complex: a Delphi consensus report.

Auvin S, Bissler JJ, Cottin V, Fujimoto A, Hofbauer GFL, Jansen AC, Jóźwiak S, Kerecuk L, Kingswood JC, Moavero R, Torra R, Villanueva V.

Orphanet J Rare Dis. 2019 Apr 30;14(1):91. doi: 10.1186/s13023-019-1072-y.

3.

Rapalog resistance is associated with mesenchymal-type changes in Tsc2-null cells.

Valianou M, Filippidou N, Johnson DL, Vogel P, Zhang EY, Liu X, Lu Y, Yu JJ, Bissler JJ, Astrinidis A.

Sci Rep. 2019 Feb 28;9(1):3015. doi: 10.1038/s41598-019-39418-5.

4.

Tuberous sclerosis complex exhibits a new renal cystogenic mechanism.

Bissler JJ, Zadjali F, Bridges D, Astrinidis A, Barone S, Yao Y, Redd JR, Siroky BJ, Wang Y, Finley JT, Rusiniak ME, Baumann H, Zahedi K, Gross KW, Soleimani M.

Physiol Rep. 2019 Jan;7(2):e13983. doi: 10.14814/phy2.13983.

5.

Renal manifestation of tuberous sclerosis complex.

Bissler JJ, Christopher Kingswood J.

Am J Med Genet C Semin Med Genet. 2018 Sep;178(3):338-347. doi: 10.1002/ajmg.c.31654. Epub 2018 Oct 11. Review.

PMID:
30307110
6.

Angiomyolipoma rebound tumor growth after discontinuation of everolimus in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis.

Bissler JJ, Nonomura N, Budde K, Zonnenberg BA, Fischereder M, Voi M, Louveau AL, Herbst F, Bebin EM, Curatolo P, Zonta A, Belousova E.

PLoS One. 2018 Sep 7;13(9):e0201005. doi: 10.1371/journal.pone.0201005. eCollection 2018.

7.

Effect of everolimus on renal function in patients with tuberous sclerosis complex: evidence from EXIST-1 and EXIST-2.

Bissler JJ, Budde K, Sauter M, Franz DN, Zonnenberg BA, Frost MD, Belousova E, Berkowitz N, Ridolfi A, Christopher Kingswood J.

Nephrol Dial Transplant. 2019 Jun 1;34(6):1000-1008. doi: 10.1093/ndt/gfy132.

8.

Effect of everolimus on skin lesions in patients treated for subependymal giant cell astrocytoma and renal angiomyolipoma: final 4-year results from the randomized EXIST-1 and EXIST-2 studies.

Franz DN, Budde K, Kingswood JC, Belousova E, Sparagana S, de Vries PJ, Berkowitz N, Ridolfi A, Bissler JJ.

J Eur Acad Dermatol Venereol. 2018 Oct;32(10):1796-1803. doi: 10.1111/jdv.14964. Epub 2018 Jul 16.

PMID:
29569806
9.

Pooled analysis of menstrual irregularities from three major clinical studies evaluating everolimus for the treatment of tuberous sclerosis complex.

Sparagana S, Franz DN, Krueger DA, Bissler JJ, Berkowitz N, Burock K, Kingswood JC.

PLoS One. 2017 Oct 12;12(10):e0186235. doi: 10.1371/journal.pone.0186235. eCollection 2017.

10.

The effect of everolimus on renal angiomyolipoma in pediatric patients with tuberous sclerosis being treated for subependymal giant cell astrocytoma.

Bissler JJ, Franz DN, Frost MD, Belousova E, Bebin EM, Sparagana S, Berkowitz N, Ridolfi A, Kingswood JC.

Pediatr Nephrol. 2018 Jan;33(1):101-109. doi: 10.1007/s00467-017-3806-1. Epub 2017 Oct 9.

11.

Everolimus long-term use in patients with tuberous sclerosis complex: Four-year update of the EXIST-2 study.

Bissler JJ, Kingswood JC, Radzikowska E, Zonnenberg BA, Belousova E, Frost MD, Sauter M, Brakemeier S, de Vries PJ, Berkowitz N, Voi M, Peyrard S, Budde K.

PLoS One. 2017 Aug 9;12(8):e0180939. doi: 10.1371/journal.pone.0180939. eCollection 2017.

12.

Primary cilia regulate the osmotic stress response of renal epithelial cells through TRPM3.

Siroky BJ, Kleene NK, Kleene SJ, Varnell CD Jr, Comer RG, Liu J, Lu L, Pachciarz NW, Bissler JJ, Dixon BP.

Am J Physiol Renal Physiol. 2017 Apr 1;312(4):F791-F805. doi: 10.1152/ajprenal.00465.2015. Epub 2017 Jan 25.

13.

Optimal treatment of tuberous sclerosis complex associated renal angiomyolipomata: a systematic review.

Bissler JJ, Kingswood JC.

Ther Adv Urol. 2016 Aug;8(4):279-290. Epub 2016 Apr 6. Review.

14.

Official American Thoracic Society/Japanese Respiratory Society Clinical Practice Guidelines: Lymphangioleiomyomatosis Diagnosis and Management.

McCormack FX, Gupta N, Finlay GR, Young LR, Taveira-DaSilva AM, Glasgow CG, Steagall WK, Johnson SR, Sahn SA, Ryu JH, Strange C, Seyama K, Sullivan EJ, Kotloff RM, Downey GP, Chapman JT, Han MK, D'Armiento JM, Inoue Y, Henske EP, Bissler JJ, Colby TV, Kinder BW, Wikenheiser-Brokamp KA, Brown KK, Cordier JF, Meyer C, Cottin V, Brozek JL, Smith K, Wilson KC, Moss J; ATS/JRS Committee on Lymphangioleiomyomatosis.

Am J Respir Crit Care Med. 2016 Sep 15;194(6):748-61. doi: 10.1164/rccm.201607-1384ST.

15.

Review of the Tuberous Sclerosis Renal Guidelines from the 2012 Consensus Conference: Current Data and Future Study.

Kingswood JC, Bissler JJ, Budde K, Hulbert J, Guay-Woodford L, Sampson JR, Sauter M, Cox J, Patel U, Elmslie F, Anderson C, Zonnenberg BA.

Nephron. 2016;134(2):51-58. Epub 2016 Aug 10. Review.

16.

Advances and Future Directions for Tuberous Sclerosis Complex Research: Recommendations From the 2015 Strategic Planning Conference.

Sahin M, Henske EP, Manning BD, Ess KC, Bissler JJ, Klann E, Kwiatkowski DJ, Roberds SL, Silva AJ, Hillaire-Clarke CS, Young LR, Zervas M, Mamounas LA; Tuberous Sclerosis Complex Working Group to Update the Research Plan.

Pediatr Neurol. 2016 Jul;60:1-12. doi: 10.1016/j.pediatrneurol.2016.03.015. Epub 2016 Apr 2.

17.

Pharmacokinetics and pharmacodynamics of everolimus in patients with renal angiomyolipoma and tuberous sclerosis complex or lymphangioleiomyomatosis.

Budde K, Zonnenberg BA, Frost M, Cheung W, Urva S, Brechenmacher T, Stein K, Chen D, Kingswood JC, Bissler JJ.

Br J Clin Pharmacol. 2016 May;81(5):958-70. doi: 10.1111/bcp.12834. Epub 2016 Mar 5.

18.

Everolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: extension of a randomized controlled trial.

Bissler JJ, Kingswood JC, Radzikowska E, Zonnenberg BA, Frost M, Belousova E, Sauter M, Nonomura N, Brakemeier S, de Vries PJ, Berkowitz N, Miao S, Segal S, Peyrard S, Budde K.

Nephrol Dial Transplant. 2016 Jan;31(1):111-9. doi: 10.1093/ndt/gfv249. Epub 2015 Jul 8.

PMID:
26156073
19.

Insight into response to mTOR inhibition when PKD1 and TSC2 are mutated.

Cabrera-López C, Bullich G, Martí T, Català V, Ballarín J, Bissler JJ, Harris PC, Ars E, Torra R.

BMC Med Genet. 2015 Jun 17;16:39. doi: 10.1186/s12881-015-0185-y.

20.

Hyperglycemia in the absence of cilia accelerates cystogenesis and induces renal damage.

Sas KM, Yin H, Fitzgibbon WR, Baicu CF, Zile MR, Steele SL, Amria M, Saigusa T, Funk J, Bunni MA, Siegal GP, Siroky BJ, Bissler JJ, Bell PD.

Am J Physiol Renal Physiol. 2015 Jul 1;309(1):F79-87. doi: 10.1152/ajprenal.00652.2014. Epub 2015 Apr 22.

21.

Therapies for polycystic kidney disease.

Bissler JJ.

Curr Opin Pediatr. 2015 Apr;27(2):227-32. doi: 10.1097/MOP.0000000000000202. Review.

PMID:
25689458
22.

Consensus expert recommendations for the diagnosis and management of autosomal recessive polycystic kidney disease: report of an international conference.

Guay-Woodford LM, Bissler JJ, Braun MC, Bockenhauer D, Cadnapaphornchai MA, Dell KM, Kerecuk L, Liebau MC, Alonso-Peclet MH, Shneider B, Emre S, Heller T, Kamath BM, Murray KF, Moise K, Eichenwald EE, Evans J, Keller RL, Wilkins-Haug L, Bergmann C, Gunay-Aygun M, Hooper SR, Hardy KK, Hartung EA, Streisand R, Perrone R, Moxey-Mims M.

J Pediatr. 2014 Sep;165(3):611-7. doi: 10.1016/j.jpeds.2014.06.015. Epub 2014 Jul 9. No abstract available.

23.

Evidence for pericyte origin of TSC-associated renal angiomyolipomas and implications for angiotensin receptor inhibition therapy.

Siroky BJ, Yin H, Dixon BP, Reichert RJ, Hellmann AR, Ramkumar T, Tsuchihashi Z, Bunni M, Dillon J, Bell PD, Sampson JR, Bissler JJ.

Am J Physiol Renal Physiol. 2014 Sep 1;307(5):F560-70. doi: 10.1152/ajprenal.00569.2013. Epub 2014 Jun 11.

24.

The effect of everolimus on renal angiomyolipoma in patients with tuberous sclerosis complex being treated for subependymal giant cell astrocytoma: subgroup results from the randomized, placebo-controlled, Phase 3 trial EXIST-1.

Kingswood JC, Jozwiak S, Belousova ED, Frost MD, Kuperman RA, Bebin EM, Korf BR, Flamini JR, Kohrman MH, Sparagana SP, Wu JY, Brechenmacher T, Stein K, Berkowitz N, Bissler JJ, Franz DN.

Nephrol Dial Transplant. 2014 Jun;29(6):1203-10. doi: 10.1093/ndt/gfu013. Epub 2014 Apr 11.

25.

Characterization of renal toxicity in mice administered the marine biotoxin domoic Acid.

Funk JA, Janech MG, Dillon JC, Bissler JJ, Siroky BJ, Bell PD.

J Am Soc Nephrol. 2014 Jun;25(6):1187-97. doi: 10.1681/ASN.2013080836. Epub 2014 Feb 8.

26.

Lymphangioleiomyomatosis screening in women with tuberous sclerosis.

Cudzilo CJ, Szczesniak RD, Brody AS, Rattan MS, Krueger DA, Bissler JJ, Franz DN, McCormack FX, Young LR.

Chest. 2013 Aug;144(2):578-585. doi: 10.1378/chest.12-2813.

PMID:
23539171
27.

Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial.

Bissler JJ, Kingswood JC, Radzikowska E, Zonnenberg BA, Frost M, Belousova E, Sauter M, Nonomura N, Brakemeier S, de Vries PJ, Whittemore VH, Chen D, Sahmoud T, Shah G, Lincy J, Lebwohl D, Budde K.

Lancet. 2013 Mar 9;381(9869):817-24.

PMID:
23312829
28.

Impact of ultrasound-guided kidney biopsy simulation on trainee confidence and biopsy outcomes.

Dawoud D, Lyndon W, Mrug S, Bissler JJ, Mrug M.

Am J Nephrol. 2012;36(6):570-4. doi: 10.1159/000345305. Epub 2012 Dec 5.

29.

Performance of cystatin C-based equations in a pediatric cohort at high risk of kidney injury.

Nehus EJ, Laskin BL, Kathman TI, Bissler JJ.

Pediatr Nephrol. 2013 Mar;28(3):453-61. doi: 10.1007/s00467-012-2341-3. Epub 2012 Nov 10.

PMID:
23142864
30.

Replication fork stalling and checkpoint activation by a PKD1 locus mirror repeat polypurine-polypyrimidine (Pu-Py) tract.

Liu G, Myers S, Chen X, Bissler JJ, Sinden RR, Leffak M.

J Biol Chem. 2012 Sep 28;287(40):33412-23. Epub 2012 Aug 6.

31.

Human TSC-associated renal angiomyolipoma cells are hypersensitive to ER stress.

Siroky BJ, Yin H, Babcock JT, Lu L, Hellmann AR, Dixon BP, Quilliam LA, Bissler JJ.

Am J Physiol Renal Physiol. 2012 Sep 15;303(6):F831-44. doi: 10.1152/ajprenal.00441.2011. Epub 2012 Jul 11.

32.

Stressed podocytes fail to fold: a potential new role of ER in FSGS.

Siroky BJ, Bissler JJ.

Am J Physiol Renal Physiol. 2011 Sep;301(3):F494-5. doi: 10.1152/ajprenal.00247.2011. Epub 2011 Jun 22. No abstract available.

33.

The human DEK oncogene regulates DNA damage response signaling and repair.

Kavanaugh GM, Wise-Draper TM, Morreale RJ, Morrison MA, Gole B, Schwemberger S, Tichy ED, Lu L, Babcock GF, Wells JM, Drissi R, Bissler JJ, Stambrook PJ, Andreassen PR, Wiesmüller L, Wells SI.

Nucleic Acids Res. 2011 Sep 1;39(17):7465-76. doi: 10.1093/nar/gkr454. Epub 2011 Jun 7.

34.

Cell cycle control and DNA damage response of conditionally immortalized urothelial cells.

Dixon BP, Henry J, Siroky BJ, Chu A, Groen PA, Bissler JJ.

PLoS One. 2011 Jan 28;6(1):e16595. doi: 10.1371/journal.pone.0016595.

35.

Tuberous sclerosis complex: neurological, renal and pulmonary manifestations.

Franz DN, Bissler JJ, McCormack FX.

Neuropediatrics. 2010 Oct;41(5):199-208. doi: 10.1055/s-0030-1269906. Epub 2011 Jan 5. Review.

36.

Clinical and molecular insights into tuberous sclerosis complex renal disease.

Siroky BJ, Yin H, Bissler JJ.

Pediatr Nephrol. 2011 Jun;26(6):839-52. doi: 10.1007/s00467-010-1689-5. Epub 2010 Dec 9. Review.

PMID:
21152937
37.

Tuberous sclerosis complex renal disease.

Dixon BP, Hulbert JC, Bissler JJ.

Nephron Exp Nephrol. 2011;118(1):e15-20. doi: 10.1159/000320891. Epub 2010 Nov 11. Review.

38.

Replication-dependent instability at (CTG) x (CAG) repeat hairpins in human cells.

Liu G, Chen X, Bissler JJ, Sinden RR, Leffak M.

Nat Chem Biol. 2010 Sep;6(9):652-9. doi: 10.1038/nchembio.416. Epub 2010 Aug 1.

39.

Simulation of real-time ultrasound-guided renal biopsy.

Mrug M, Bissler JJ.

Kidney Int. 2010 Oct;78(7):705-7. doi: 10.1038/ki.2010.213. Epub 2010 Jul 14.

40.

Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases.

Young LR, Vandyke R, Gulleman PM, Inoue Y, Brown KK, Schmidt LS, Linehan WM, Hajjar F, Kinder BW, Trapnell BC, Bissler JJ, Franz DN, McCormack FX.

Chest. 2010 Sep;138(3):674-81. doi: 10.1378/chest.10-0573. Epub 2010 Apr 9.

41.

Glomerulocystic kidney disease.

Bissler JJ, Siroky BJ, Yin H.

Pediatr Nephrol. 2010 Oct;25(10):2049-56; quiz 2056-9. doi: 10.1007/s00467-009-1416-2. Epub 2010 Jan 21. Review.

42.

Increased cancer risk of augmentation cystoplasty: possible role for hyperosmolal microenvironment on DNA damage recognition.

Dixon BP, Chu A, Henry J, Kim R, Bissler JJ.

Mutat Res. 2009 Nov 2;670(1-2):88-95. doi: 10.1016/j.mrfmmm.2009.07.010. Epub 2009 Jul 30.

43.

Automated algorithm for quantifying the extent of cystic change on volumetric chest CT: initial results in Lymphangioleiomyomatosis.

Schmithorst VJ, Altes TA, Young LR, Franz DN, Bissler JJ, McCormack FX, Dardzinski BJ, Brody AS.

AJR Am J Roentgenol. 2009 Apr;192(4):1037-44. doi: 10.2214/AJR.07.3334.

PMID:
19304711
44.

Renal involvement in tuberous sclerosis complex and von Hippel-Lindau disease: shared disease mechanisms?

Siroky BJ, Czyzyk-Krzeska MF, Bissler JJ.

Nat Clin Pract Nephrol. 2009 Mar;5(3):143-56. doi: 10.1038/ncpneph1032. Review.

PMID:
19240728
45.

Nephritic factor and recurrence in the renal transplant of membranoproliferative glomerulonephritis type II.

West CD, Bissler JJ.

Pediatr Nephrol. 2008 Oct;23(10):1867-76. doi: 10.1007/s00467-008-0887-x. Epub 2008 Jul 2.

PMID:
18594868
46.

RecQ and RecG helicases have distinct roles in maintaining the stability of polypurine.polypyrimidine sequences.

Dixon BP, Lu L, Chu A, Bissler JJ.

Mutat Res. 2008 Aug 25;643(1-2):20-8. doi: 10.1016/j.mrfmmm.2008.05.005. Epub 2008 Jun 7.

47.

Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis.

Bissler JJ, McCormack FX, Young LR, Elwing JM, Chuck G, Leonard JM, Schmithorst VJ, Laor T, Brody AS, Bean J, Salisbury S, Franz DN.

N Engl J Med. 2008 Jan 10;358(2):140-51. doi: 10.1056/NEJMoa063564.

49.

Replication protein A is required for etoposide-induced assembly of MRE11/RAD50/NBS1 complex repair foci.

Robison JG, Bissler JJ, Dixon K.

Cell Cycle. 2007 Oct 1;6(19):2408-16. Epub 2007 Jul 20.

PMID:
17700070
50.

Supplemental Content

Loading ...
Support Center